Answer:
The statement which indicates that the patient has an accurate understanding of the new medication is; I have read that carbidopa-levodopa is quite short-acting so I will have to take it several times a day.
Explanation:
The half-life of both carbidopa-levodopa medication is approximately 2 hours with duration of action of a dose of 5 hours. This means that patients must take it more than once daily.
In addition, carbidopa-levodopa does not change the course of the Parkinson's disease and prescribed doses are not usually based on the short-term severity of symptoms. Hence, the patient's medications history must be evaluated.
Answer:
Get Ana to watch Mickey and Dora, they can make learning fun for children her age and watch it with her too. Alternatively, just be patient with her, and guide her through reading.
Explanation:
I have a cousin.
This disease is called Parkinsons!
Hope this helps!
Answer:
Lack of clarity in communication between physicians treating the patient leading to failure to follow through with evaluation and treatment plans. Incorrect treatment decisions compromising patient safety. Loss of practice revenue.
Your brain and heart hope this helps
